title: [Nitrofurantoïne, recommendations to be followed to reduce severe complications occurency risk].
authors: Centre hospitalier de Saint-Malo, service de pharmacie, 1, rue de la Marne, 35400 Saint-Malo, France. Electronic address: renard.carmen@gmail.com.
authors: Carmen
authors: C
authors: Renard
authors: Centre hospitalier de Saint-Malo, service de pharmacie, 1, rue de la Marne, 35400 Saint-Malo, France.
authors: Marie-Amélie
authors: MA
authors: Laigneau
authors: Centre hospitalier de Saint-Malo, service de néphrologie, 1, rue de la Marne, 35400 Saint-Malo, France.
authors: Eric
authors: E
authors: Renaudineau
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology / Q000517:prevention & control; D000075202:Contraindications; D004342:Drug Hypersensitivity / Q000209:etiology; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000276:immunology / Q000517:prevention & control; D008171:Lung Diseases / Q000139:chemically induced / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D009582:Nitrofurantoin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D014552:Urinary Tract Infections / Q000188:drug therapy
chemical_list: D009582:Nitrofurantoin